Skip to main content
Log in

Perianal fistulas in Crohn’s disease: MRI diagnosis and surgical planning

MRI in fistulazing perianal Crohn’s disease

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Crohn’s disease is a chronic, transmural inflammatory process of the gastrointestinal tract. It often affects the colon with the perianal area. The most common intestinal manifestations include external and/or internal fistulas and abscesses. Assessment of the activity of perianal fistulas in the course of Crohn’s disease seems to be an important factor influencing therapeutic approach. Fistula’s activity is evaluated by such methods as magnetic resonance imaging, anal ultrasound and examination under anaesthesia. Usefulness of imaging methods in the diagnosis of fistulas still remains to be defined.

MRI is used to present a wide spectrum of perianal fistulazing Crohn’s disease. Additionally, it is an important instrument revealing location, extent and severity of inflammation. It is also very helpful to detect clinically silent sepsis related to small, local inflammation. The most common method used in MR imaging to assess topography of a fistula’s track, is Parks’ classification.

Clinical indications to MRI may include follow-up studies of a diagnosed disease, classification of fistulas’ subtypes in the course of Crohn’s disease, determination of the extent of fistulas’ tracts and spread of an inflammatory process what can guide surgical procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.
Fig. 10.
Fig. 11.
Fig. 12.
Fig. 13.
Fig. 14.
Fig. 15.
Fig. 16.
Fig. 17.
Fig. 18.
Fig. 19.
Fig. 20.
Fig. 21.
Fig. 22.
Fig. 23.
Fig. 24.
Fig. 25.
Fig. 26.
Fig. 27.
Fig. 28.
Fig. 29.
Fig. 30.
Fig. 31.
Fig. 32.
Fig. 33.
Fig. 34.
Fig. 35.
Fig. 36.
Fig. 37.
Fig. 38.
Fig. 39.
Fig. 40.
Fig. 41.
Fig. 42.
Fig. 43.
Fig. 44.

Similar content being viewed by others

References

  1. Young Y, Abreu MT. (2006) Advances in the pathogenesis of inflammatory bowel disease. Curr Gastroenterol Rep. 8: 470–477

    Article  PubMed  Google Scholar 

  2. Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. (2002) The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 122: 875–880

    Article  PubMed  Google Scholar 

  3. Hellers G, Bergstrand O, Ewerth S, Holmstrom B. (1980) Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease. Gut. 1980; 21:525

    Article  CAS  Google Scholar 

  4. Kamm MA. (2006) Review article: biological drugs in Crohn’s disease. Aliment Pharmacol Ther. 24 (Suppl 3): 80–89

    Article  PubMed  CAS  Google Scholar 

  5. Schwartz DA, Wiersema MJ, Dudiak KM, et al. (2000) A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology; 121: 1064–1072

    Article  Google Scholar 

  6. Bressler B, Sands BE. (2006) Review article: Medical therapy for fistulizing Crohn’s disease. Aliment Pharmacol Ther. 24: 1283–1293

    Article  PubMed  CAS  Google Scholar 

  7. Buchanan G, Halligan S, Williams A, et al. (2002) Effect of MRI on clinical outcome of recurrent fistula-in-ano. Lancet 360:1661–1662

    Article  PubMed  Google Scholar 

  8. Sandborn WJ, Fazio VW, Feagan BG, et al. (2003) AGA technical review on perianal Crohn’s disease. Gastroenterology 125: 1508–1530

    Article  PubMed  Google Scholar 

  9. Present DH, Rutgeerts P, Targan S, et al. (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340: 1398–1405

    Article  PubMed  CAS  Google Scholar 

  10. Sands BE, Anderson FH, Bernstein CN, et al. (2004) Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 350: 876–885

    Article  PubMed  CAS  Google Scholar 

  11. Sandborn WJ, Feagan BG, Hanauer SB, et al. (2002) A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology 122:512–530

    Article  PubMed  Google Scholar 

  12. Bell SJ, Halligan S, Windsor AC, et al. (2003) Response of fistulating Crohn’s disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 17:387–393

    Article  PubMed  CAS  Google Scholar 

  13. American Gastroenterological Association. (2003) AGA technical review on perianal Crohn’s disease. Gastroenterology 125: 1508–1530

    Article  Google Scholar 

  14. HalliganS, Buchanan G. (2003) MR imaging of fistula-in-ano. Eur J Radiol. 47: 98–107

    Article  Google Scholar 

  15. Irvine EJ. (1995) Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. J Clin Gastroenterol 20: 27–32

    Article  PubMed  CAS  Google Scholar 

  16. Caprilli R, Viscido A, Guagnozzi D. (2002) Review article: biological agents in the treatment of Crohn’s disease. Aliment Pharmacol Ther. 16: 579–590

    Article  Google Scholar 

  17. Kuijpers HC, Schulpen T. (1985) Fistulography for fistula-in-ano. Is it useful? Dis Colon Rectum. 28: 103–104

    Article  CAS  Google Scholar 

  18. Furukawa A, Saotome T, Yamasaki M, Maeda K, Nitta N, Takahashi M, Tsujikawa T, Fujiyama Y, Murata K, Sakamoto T (2004) Cross-sectional imaging in Crohn disease. Radiographics. 24: 689–702

    Article  PubMed  Google Scholar 

  19. Choen S, Burnett S, Bartram CI, Nicholls RJ. (1991) Comparison between anal endosonography and digital examination in the evaluation of anal fistulae. Br J Surg. 78: 445–447

    Article  PubMed  CAS  Google Scholar 

  20. Singh B, McC Mortensen NJ, Jewell DP, George B. (2004) Perianal Crohn’s disease. Br J Surg. 91: 801–814

    Article  PubMed  CAS  Google Scholar 

  21. Beets-Tan RG, Beets GL, van der Hoop AG, Kessels AG, Vliegen RF, Baeten CG, van Engelshoven JM. (2001) Preoperative MR imaging of anal fistulas: Does it really help the surgeon? Radiology. 218: 75–84

    PubMed  CAS  Google Scholar 

  22. Haggett PJ, Moore NR, Shearman JD, Travis SP, Jewell DP, Mortensen NJ. (1995) Pelvic and perineal complications of Crohn’s disease: assessment using magnetic resonance imaging. Gut 36: 407–410

    Article  PubMed  CAS  Google Scholar 

  23. Morris J, Spencer JA, Ambrose NS. (2000) MR imaging classification of perianal fistulas and its implications for patient management. Radiographics. 20: 623–635

    PubMed  CAS  Google Scholar 

  24. Horsthuis K, Stoker J. (2004) MRI of perianal Crohn’s Disease. AJR Am J Roentgenol. 183: 1309–1315

    PubMed  Google Scholar 

  25. Parks AG, Gordon PH, Hardcastle JD. (1976) A classification of fistula-in-ano. Br J Surg. 63: 1–12

    Article  PubMed  CAS  Google Scholar 

  26. Buchanan GN, Halligan S, Taylor S, Williams A, Cohen R, Bartram C. (2004) MRI of fistula in ano: inter- and intraobserver agreement and effects of directed education. AJR Am J Roentgenol. 183:135–140

    PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge Dorota Borowska in preparing the figures and diagrams.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edyta Szurowska MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szurowska, E., Wypych, J. & Izycka-Swieszewska, E. Perianal fistulas in Crohn’s disease: MRI diagnosis and surgical planning. Abdom Imaging 32, 705–718 (2007). https://doi.org/10.1007/s00261-007-9188-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-007-9188-2

Keywords

Navigation